Terbinafine is withdrawn from market due to?

Why was terbinafine withdrawn from the market?

Terbinafine has been withdrawn from some markets or restricted in certain countries due to safety concerns—most notably severe skin reactions and liver-related adverse effects that regulators considered serious enough to warrant action.

Which safety problems drive the withdrawal?

Regulatory actions involving terbinafine commonly focus on:
- Serious liver injury (including cases of severe hepatitis or liver failure).
- Severe cutaneous reactions (for example, reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis).
These risks are the main reason terbinafine has faced market withdrawals or strengthened prescribing restrictions in some jurisdictions.

Was the withdrawal nationwide or limited?

Withdrawals have varied by country and by product/manufacturer. In some places, regulators have pulled specific formulations, while in others they have restricted use, added stronger warnings, or required tighter monitoring rather than a complete market withdrawal.

Are there alternatives if terbinafine is pulled where you live?

If terbinafine is unavailable, clinicians often consider other antifungals depending on the condition being treated (for example, topical azoles like clotrimazole or oral options like itraconazole or fluconazole, guided by the infection type and patient risk factors).